Presentation description

Four leiomyosarcoma cell lines were focused on in the present investigation using the perspective of evolutionary and Darwinian medicine and comparative oncology to develop ways to better predict, prevent, and treat cancer in the clinic. The leiomyosarcoma cell lines were transfected and treated with combinations of elephant p53 (EP53), R9, human P53 (TP53), and doxorubicin vectors.